Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound could guide emergency bleeding control

NCT ID NCT07707921

Knowledge-focused Sponsor: Tel-Aviv Sourasky Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether pressing on the abdomen with an ultrasound probe can temporarily stop blood flow in the main artery (aorta) in healthy adults aged 18-40. The goal is to see if this technique is effective and tolerable, potentially offering a more accurate way to control severe bleeding in emergencies. Participants will have their abdominal aorta compressed under ultrasound guidance for up to 30 seconds while blood flow is monitored.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound-guided external abdominal aortic compression
What this could lead to
If successful, this technique could provide a more precise way to control severe bleeding in emergencies, potentially saving lives.
What could go wrong
This is a small feasibility study in healthy volunteers, so results may not translate to real trauma situations. The technique may be difficult to perform or cause discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-40 years. * Informed consent. Exclusion Criteria: * Any known abdominal or vascular pathology. * Any known peripheral neuropathy. * BMI\>30. * Sensitivity to ultrasonic gel. * Tendency for syncope/ pre-syncope during blood-drawing, intravenous cannulation, etc. * Personnel actively serving in the IDF. * Pregnant/ possibly pregnant individuals. * People lacking the ability to give informed consent. * All of the above will be based on subjects' self-reporting. Subjects will be encouraged to consult with their physician.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy volunteers

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tel Aviv Medical Center

    Tel Aviv, Tel Aviv, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.